Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
This study has been withdrawn prior to enrollment.
Study NCT00354367   Information provided by UCB, Inc.

First Received on July 18, 2006.   Last Updated on May 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn Disease
Additional conditions recognized in this trial
Fistula
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Pathological Conditions, Anatomical
Interventions listed in this trial
Certolizumab pegol
Additional drug interventions recognized in this trial
Immunoglobulin Fab Fragments
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
UCB, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services